MiniMed Group (MMED) SEC filings document the regulatory record of a Nasdaq-listed diabetes technology company focused on insulin delivery systems, CGMs, sensors, algorithms, and app-connected diabetes management. MiniMed's filings include annual reports, quarterly reports, proxy statements, and Form 8-K material event reports.
For MMED, the most relevant filings often relate to medical device operations and newly public company governance. Annual reports and 10-Q filings can describe business structure, risk factors, capital structure, financial results, clinical and regulatory matters, and disclosures tied to MiniMed's separation from Medtronic. Form 8-K filings have covered financial results, board appointments, executive compensation plans, officer departures, cybersecurity-related disclosures, and other material events.
Proxy statements are useful for reviewing director elections, auditor ratification, advisory compensation votes, and governance matters. Form 4 insider transaction filings can show reported purchases, sales, or equity awards by directors and officers when such filings are submitted. 10-K and 10-Q reports are especially important for understanding how MiniMed reports its diabetes technology business after becoming a public company.
AI-powered summaries can translate dense filing language into plain-English explanations, while real-time EDGAR updates can surface new MMED filings as they are released. These summaries are most useful when reviewing long annual reports, quarterly updates, proxy statements, and insider transaction disclosures.
MiniMed Group, Inc. director Mauri Laura has filed an initial insider ownership report on Form 3 for shares of MMED. The filing lists Mauri as a director and reports no insider stock transactions or derivative positions in the data provided.
MiniMed Group, Inc. director Timothy A. Wicks filed an initial ownership report on Form 3. The filing does not list any common stock or derivative transactions, serving as a baseline disclosure of his status as a director of the company.
MiniMed Group, Inc. filed an initial Form 3 for director Robert (Bob) Hopkins, formally registering him as an insider of the company. The filing shows no reported purchases, sales, gifts, exercises, or other transactions, and lists no derivative securities positions in the provided data.
MiniMed Group, Inc. director D. Keith Grossman filed an initial Form 3 insider ownership report for MMED. This filing establishes his status as a director and provides a baseline disclosure of his beneficial ownership. The report shows no insider transactions or derivative positions in this submission.
MiniMed Group, Inc. director Glenn A. Eisenberg filed an initial statement of beneficial ownership on Form 3. This filing establishes his status as a reporting insider of the company. The filing does not list any equity transactions or existing derivative positions.
MiniMed Group, Inc. director Kevin E. Lofton filed an initial Form 3 reporting his status as an insider of the company. The filing does not list any common stock or derivative holdings and shows no reported purchases, sales, exercises, gifts, or other transactions.
MiniMed Group, Inc. officer Gyurci John filed an initial Form 3 reporting his status as a company officer. This is a baseline ownership filing required when someone becomes subject to insider reporting rules. The filing does not report any transactions or derivatives positions in MiniMed Group stock.
MiniMed Group, Inc. filed an initial insider ownership report for officer Chandrasena Gillian on Form 3. The data provided shows no reported transactions, no buy or sell activity, and no derivative positions, indicating this filing is primarily a baseline disclosure of status as an officer.
MiniMed Group, Inc. officer Wills Courtney Nelson filed an initial Form 3, which is a required statement of beneficial ownership for company insiders. This filing shows no reportable holdings or transactions in MiniMed Group securities in the data provided.
MiniMed Group, Inc. executive Dianaty Ali filed an initial Form 3, which is a required statement of beneficial ownership for insiders. This filing does not report any equity transactions or any current holdings of MiniMed Group securities, and serves mainly as a baseline disclosure of insider status.